17.9 C
New York
Thursday, May 19, 2022

Why did the Natus Medical Incorporated (NTUS) Stock increase by more than 30% today?

Natus Medical Incorporated (NTUS) stock surged in the current market after announcing it to be acquired by ArchiMed and provided preliminary results. NTUS stock values at $33.63, gaining more than 30% from the previous close. NTUS stock previously closed at $26.05 with a trading volume of around 151.82K shares.


Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored


Brian Diseases Industry Dynamics

Natus Medical Incorporated (NTUS) is a major player in the medical device solution provider that helps physicians screen, diagnose, and treat diseases related to the nervous system and brain. The industry of medical devices that treat brain diseases is driven by many factors such as neurological disorders and the advancement in the integration of Artificial Intelligence in the devices.

The global brain disease industry and software market was valued at $13 billion at the end of fiscal 2021. It is expected to grow at a compound annual growth rate of 5.3% to reach $21.8 billion between 2022 and 2031.

ArchiMed acquires NTUS

Natus Medical Incorporated (NTUS) announced today that it has entered into a formal agreement to be purchased by an affiliate of ArchiMed for roughly $1.2 billion in cash, a premier investment group that focuses only on the healthcare business. As part of the deal, Natus stockholders will receive $33.50 in cash for each share of Natus common stock they own as of April 14, 2022. This represents a 29 percent premium over the closing price of the Company’s common stock on that day.

NTUS Q1 2022 Preliminary Results

  • According to the company, the first-quarter 2022 revenue was $119.8 million, an increase of 4.3 percent from $114.9 million in the first quarter of 2021.
  • While purchasing semiconductors in the first quarter of 2022, Natus spent $3.4 million in supply chain expenditures.
  • The company had $84 million in cash at the end of the quarter, up from $75.6 million at the start of the quarter. There was no debt.
  • After the market closes on Thursday, May 5, the company will reveal its first-quarter financial statement for 2022.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles